doi: 10.1146/annurev.pharmtox.42.083001.144616 86 DenuJMTannerKG
Packer recently proposed an intriguing hypothesis that DPP-4 inhibitors potentiate some endogenous peptides, such as stromal cell-derived factor-1, in addition to activation of GLP-1, and that unfavorable effects of those peptides on CV parameters (e.g., inflammation, fibrosis, plaque growth, and sympathetic activation) could prevail against the CV protective effects of GLP-1, possibly leading to worsened CV complications and HF [36, 37]
How IV Therapy Works IV therapy is designed to provide efficient nutrient delivery, allowing your body to absorb essential hydration, vitamins, and antioxidants more effectively than oral supplements
[DOI] [PMC free article] [PubMed] [Google Scholar] [216].Fonte P, Araujo F, Reis S, Sarmento B, Oral insulin delivery: how far are we?, J Diabetes Sci Technol, 7 (2013) 520531
The body makes enough GLP-1, PYY and GIP to handle the job